- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT06476678
Nova faca de ablação por radiofrequência bipolar em lesões esofágicas
Ensaio multicêntrico prospectivo que avalia a eficácia e a viabilidade de uma nova faca de ablação por radiofrequência bipolar na dissecção endoscópica da submucosa esofágica
Both Baylor St Luke's Medical Center and Mayo Scottsdale are considered endoscopic submucosal dissection (ESD) centers of excellence. The investigators at Baylor College of Medicine have previously reported our Esophageal ESD experience using the monopolar current knife. Moreover, the research team have previously reported on the clinical efficacy of the bipolar RFA knife during per-oral endoscopic myotomy (POEM) and colonic ESD. The goal of our study is to prospectively evaluate the efficacy, safety and feasibility of Esophageal ESD using a novel Bipolar-Current ESD device.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Endoscopic submucosal dissection (ESD) is a novel technique for the removal of esophageal lesions or polyps with high-risk features. ESD is minimally invasive and allows the removal of esophageal polyps without resorting to morbid surgery. The process of ESD includes marking the lesions selected for removal, followed by submucosal injection of a lifting agent, then circumferential incisions using a specialized knife followed by submucosal dissection of the entire lesion.
Traditionally, knifes utilizing monopolar current were the preferred tools for endoscopic submucosal dissection. These knifes allow accurate dissection and excellent hemostasis. However, due to monopolar current generated heat, post coagulation syndrome can be seen in up to 8 to 40 % of patients. Post coagulation syndrome present with pain, fever and leukocytosis and requires supportive treatment with IV fluid and antibiotics. In addition, for large esophageal lesions, stricturing can occur after resection due to significant scar formation resulting from the tissue healing response to electrocautery. Almost all patients with >60% of the esophageal circumference removed via monopolar knives, will develop an esophageal stricture at some point. These patients require serial esophageal dilations, and although easily managed, its development can be quite troublesome to the patient. Nevertheless, ESD is still the preferred modality for removal of these lesions since it avoids the need for morbid surgery.
Recently, a novel Bipolar RFA knife was FDA approved for endoscopic submucosal dissection. The low voltage bipolar system allows for precise cutting of submucosa and muscle using substantially less energy, thereby limiting inadvertent remote thermal effects. Additionally, it allows aggressive coagulation of vessels without dissipation of large amounts of energy, thereby allowing more targeted therapy. Moreover, with the addition of an integrated injection needle, the knife now allows injection, safe cutting and coagulation in one device, potentially supporting more efficient dissection. Ultimately, due to less thermal effect on surrounding tissue, the bipolar knife may allow for removal of large esophageal lesions without causing major esophageal stricturing.
Tipo de estudo
Inscrição (Estimado)
Contactos e Locais
Contato de estudo
- Nome: Salmaan A Jawaid, MD
- Número de telefone: 7137980950
- E-mail: Salmaan.Jawaid@bcm.edu
Estude backup de contato
- Nome: Haydee Rochits Cueto
- Número de telefone: 7137983606
- E-mail: Haydee.RochitsCueto@bcm.edu
Locais de estudo
-
-
Texas
-
Houston, Texas, Estados Unidos, 77030
- Recrutamento
- Baylor College of Medicine
-
Investigador principal:
- Salmaan Jawaid, MD
-
Subinvestigador:
- Mohamed Othman, MD
-
Contato:
- Salmaan Jawaid, MD
- Número de telefone: 713-798-0950
- E-mail: Salmaan.Jawaid@bcm.edu
-
Subinvestigador:
- Tara Keihanian, MD
-
Contato:
- Haydee Rochits Cueto
- Número de telefone: 7137983606
- E-mail: Haydee.RochitsCueto@bcm.edu
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
All patients undergoing intended ESD of precancerous lesions will be screened by study coordinators for preliminary eligibility and those who meet the inclusion criteria will be approach individually for further discussion about the study and obtaining informed consent.
Descrição
Inclusion Criteria:
-
Patient is >18 years of age
-
Patient can provide informed consent
-
Patient is referred for resection of precancerous lesions meeting the following criteria:
- Mucosal based polyp
- Located gastroesophageal junction (GEJ) or proximal to GEJ
- No previous endoscopic resection attempted (EMR or ESD)
Exclusion Criteria:
- Patients with International Normalized Ratio (INR) >1.5 or Platelets <50,000
- Lesions extending past GEJ
- Subepithelial lesions
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Modelos de observação: CASE_ONLY
- Perspectivas de Tempo: PROSPECTIVE
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
|---|---|
|
Treatment arm
Patients who were deemed eligible and signed the consent will undergo the removal of their esophageal precancerous lesion utilizing the novel bipolar knife during their endoscopic submucosal dissection (ESD). |
Use of Speedboat™ Ultraslim for performing endoscopic submucosal dissection of esophageal lesions. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Technical success
Prazo: Day 1 (procedure day)
|
Defined as the ability to perform the entire dissection (procedure) with the novel bipolar knife |
Day 1 (procedure day)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Speed of Endoscopic Submucosal Dissection
Prazo: During Procedure
|
The speed of endoscopic submucosal dissection as calculated by cm^2/hour |
During Procedure
|
|
Number of instruments used
Prazo: During Procedure
|
Logging the variable equipment utilized during the procedure |
During Procedure
|
|
Rate of muscle injury score
Prazo: During Procedure
|
As calculated by the Sydney Classification of Deep Mural Injury ranging from Type 0 - Type V with Type V as the most severe score. |
During Procedure
|
|
Rate of post-electrocautery syndrome
Prazo: 24 hours, 2 weeks, and 4 weeks
|
Define as post-procedure abdominal pain, fevers, leukocytosis |
24 hours, 2 weeks, and 4 weeks
|
|
Change in post-procedural pain score
Prazo: 24 hours, 2 weeks, and 4 weeks
|
As calculated by the visual analog pain scale to measure patient pain ranging from 0-10 with 10 being the most pain. |
24 hours, 2 weeks, and 4 weeks
|
|
Rate of esophageal stricturing
Prazo: Assessed at any follow-up post-procedure endoscopies up to 6 months
|
Calculated by number of documented occurrences post-procedure for subjects |
Assessed at any follow-up post-procedure endoscopies up to 6 months
|
|
Degree of scar formation
Prazo: Assessed at any follow-up post-procedure endoscopies up to 6 months
|
Scar formation that occurs in response to electrocautery |
Assessed at any follow-up post-procedure endoscopies up to 6 months
|
|
Cost of dissection
Prazo: During Procedure
|
As calculated upon review of devices used during dissection procedure |
During Procedure
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- H-55206
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
produto fabricado e exportado dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .